Get the Stockscreener App
2.52
3.08%
-0.08
Ventyx Biosciences Inc stock is traded at $2.52, with a volume of 429.27K.
It is down -3.08% in the last 24 hours and down -2.33% over the past month.
Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.
See More
Previous Close:
$2.60
Open:
$2.62
24h Volume:
429.27K
Relative Volume:
0.34
Market Cap:
$179.70M
Revenue:
-
Net Income/Loss:
$-192.96M
P/E Ratio:
-0.7636
EPS:
-3.3
Net Cash Flow:
$-167.04M
1W Performance:
+5.00%
1M Performance:
-2.33%
6M Performance:
+65.79%
1Y Performance:
+16.13%
1-Day Range:
$2.50
$2.6728
1-Week Range:
$2.37
$2.6728
52-Week Range:
$0.783
$3.39
Ventyx Biosciences Inc Stock (VTYX) Company Profile
Name
Ventyx Biosciences Inc
Sector
Industry
Phone
(858) 945-2393
Address
12790 EL CAMINO REAL, SUITE 200, SAN DIEGO
Compare VTYX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VTYX
Ventyx Biosciences Inc
|
2.52 | 185.40M | 0 | -192.96M | -167.04M | -3.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Ventyx Biosciences Inc Stock (VTYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-12-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-12-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Nov-07-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-07-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-07-23 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-07-23 | Downgrade | Stifel | Buy → Hold |
| Nov-07-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jun-14-23 | Resumed | Credit Suisse | Outperform |
| Mar-21-23 | Initiated | Wells Fargo | Overweight |
| Dec-19-22 | Initiated | Goldman | Buy |
| Nov-17-22 | Initiated | Morgan Stanley | Overweight |
| Sep-07-22 | Initiated | Stifel | Buy |
| Sep-01-22 | Initiated | H.C. Wainwright | Buy |
| May-09-22 | Initiated | Credit Suisse | Outperform |
| Mar-31-22 | Initiated | Canaccord Genuity | Buy |
| Feb-01-22 | Initiated | Oppenheimer | Outperform |
| Nov-15-21 | Initiated | Jefferies | Buy |
| Nov-15-21 | Initiated | Piper Sandler | Overweight |
View All
Ventyx Biosciences Inc Stock (VTYX) Latest News
Quantitative breakdown of Ventyx Biosciences Inc. recent moveTrade Volume Report & Daily Market Momentum Tracking - Newser
Applying chart zones and confluence areas to Ventyx Biosciences Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - Newser
How to forecast Ventyx Biosciences Inc. trends using time seriesJuly 2025 Fed Impact & Free Community Supported Trade Ideas - Newser
Technical analysis overview for Ventyx Biosciences Inc. stockJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Regression analysis insights on Ventyx Biosciences Inc. performanceCPI Data & AI Based Buy/Sell Signal Reports - Newser
Options Flow: Does Ventyx Biosciences Inc. have pricing powerBreakout Watch & High Accuracy Buy Signal Tips - خودرو بانک
Ventyx Biosciences at Wells Fargo Conference: Inflammasome Leadership By Investing.com - Investing.com Canada
What are the risks of holding Ventyx Biosciences Inc.2025 Performance Recap & Smart Swing Trading Alerts - خودرو بانک
What machine learning models say about Ventyx Biosciences Inc.Dividend Hike & Real-Time Stock Movement Alerts - Newser
Investors in Ventyx Biosciences, Inc. Should Contact Levi & Korsinsky Before April 30, 2024 to Discuss Your RightsVTYX - ACCESS Newswire
Is Ventyx Biosciences Inc. stock entering bullish territoryStop Loss & Weekly Top Stock Performers List - Newser
Ventyx Biosciences Inc. stock outlook for YEAR2025 Trade Ideas & Real-Time Chart Breakout Alerts - Newser
Is now a turning point for Ventyx Biosciences Inc.July 2025 Trade Ideas & Safe Entry Point Alerts - Newser
Risk adjusted return profile for Ventyx Biosciences Inc. analyzed2025 Earnings Impact & Daily Market Momentum Tracking - Newser
Understanding Ventyx Biosciences Inc.’s price movementQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - Newser
Full technical analysis of Ventyx Biosciences Inc. stockJuly 2025 Fed Impact & Daily Chart Pattern Signal Reports - Newser
Using Bollinger Bands to evaluate Ventyx Biosciences Inc.Inflation Watch & Expert Approved Trade Ideas - Newser
What MACD and RSI say about Ventyx Biosciences Inc.Weekly Gains Report & Fast Exit Strategy with Risk Control - Newser
Can Ventyx Biosciences Inc. lead its sector in growthQuarterly Portfolio Report & Long-Term Growth Stock Strategies - خودرو بانک
Identifying reversal signals in Ventyx Biosciences Inc.2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
What Fibonacci levels say about Ventyx Biosciences Inc. reboundWeekly Gains Summary & Long Hold Capital Preservation Plans - Newser
Volume spikes in Ventyx Biosciences Inc. stock – what they meanJuly 2025 Review & Technical Buy Zone Confirmation - Newser
Will Ventyx Biosciences Inc. outperform the market in YEAR2025 Bull vs Bear & High Accuracy Investment Signals - خودرو بانک
How to use Fibonacci retracement on Ventyx Biosciences Inc.July 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
What MACD signals say about Ventyx Biosciences Inc.July 2025 Fed Impact & Daily Stock Trend Reports - Newser
What is the next catalyst for Ventyx Biosciences Inc.2025 Buyback Activity & Smart Investment Allocation Insights - خودرو بانک
Order flow analysis tools used on Ventyx Biosciences Inc.July 2025 PreEarnings & Verified Technical Trade Signals - Newser
Is Ventyx Biosciences Inc. benefiting from interest rate changesQuarterly Market Summary & High Return Trade Opportunity Guides - خودرو بانک
Is Ventyx Biosciences Inc. a potential multi bagger2025 Trading Recap & AI Powered Buy/Sell Recommendations - خودرو بانک
Is Ventyx Biosciences Inc. currently under institutional pressure2025 Year in Review & Real-Time Buy Signal Alerts - خودرو بانک
Trend Dashboard Flags Ventyx Biosciences Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - 강소기업뉴스
Building trade automation scripts for Ventyx Biosciences Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - Newser
Ventyx Biosciences Inc. Hits Price Floor — Bounce Incoming getLinesFromResByArray error: size == 0 - 강소기업뉴스
Is Ventyx Biosciences Inc. forming a bottoming baseNew Guidance & Accurate Buy Signal Notifications - Newser
Why Ventyx Biosciences Inc. stock attracts strong analyst attentionWeekly Trade Analysis & Accurate Buy Signal Alerts - Newser
What technical models suggest about Ventyx Biosciences Inc.’s comebackRate Cut & Weekly Market Pulse Updates - Newser
Why Ventyx Biosciences Inc. stock attracts strong analyst attention getLinesFromResByArray error: size == 0 - 시사인 투데이
Ventyx Biosciences Inc Stock (VTYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):